A major new review published this week challenges the growing enthusiasm for medical cannabis as a treatment for insomnia, finding surprisingly little reliable evidence that it improves sleep quality, sleep duration, or daytime functioning. Researchers who conducted the comprehensive analysis of existing clinical studies said the findings should temper expectations around cannabis-based sleep aids, which have proliferated in recent years amid loosening regulations and rising consumer demand. The review examined available trial data and concluded that most studies were too small, too short, or lacked adequate controls to draw firm conclusions about the drug's effectiveness for sleep disorders.
The authors were careful to note that the findings do not mean cannabis is ineffective for sleep, only that the current body of research is too weak to establish whether it works. They called for larger, rigorously designed clinical trials with standardized dosing and objective sleep measures to determine whether cannabinoids offer genuine therapeutic benefit. The review arrives as medical cannabis prescriptions continue to climb in several countries, and experts say the gap between widespread public enthusiasm and the available scientific evidence underscores the need for more robust research before cannabis is widely embraced as a first-line insomnia treatment.
Independent reporting synthesized from primary wires and global correspondents.